J. Welborn

发表

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.

D. Gandara, P. Lara, F. Meyers, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer.

G. Denardo, S. Denardo, S. Shen, 1997, Anticancer research.

Platelet activation in patients with sickle cell disease

T. Wun, A. Rangaswami, F. Tablin, 1998, British journal of haematology.

Platelet-erythrocyte adhesion in sickle cell disease.

T. Wun, N. Walker, F. Tablin, 1999, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial.

J. Doroshow, F. Appelbaum, S. Balcerzak, 1995, Leukemia.

An Evaluation of Barriers to Accrual in the Era of Legislation Requiring Insurance Coverage of Cancer Clinical Trial Costs in California

L. Beckett, D. Gandara, H. Chew, 2004, Cancer journal.

Identification of four new translocations involving FGFR1 in myeloid disorders

G. Martinelli, D. Oscier, M. Corcoran, 2001, Genes, chromosomes & cancer.

Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis.

A. Hagemeijer, A. de Klein, H. Beverloo, 1995, Cancer research.

A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia

R. O’Donnell, J. Tuscano, T. Wun, 2019, American journal of hematology.

Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults

J. Welborn, 1994, American journal of hematology.

Prospective E valuation o f C ancer C linical T rial A ccrual Patterns: I dentifying P otential B arriers t o E nrollment

D. Gandara, P. Lara, F. Meyers, 2001 .

Rapid improvement of thrombotic thrombocytopenic purpura with vincristine and plasmapheresis

J. Welborn, M. Acevedo, P. Emrick, 1990, American journal of hematology.

Mast cell disease followed by leukemia with clonal evolution.

F. Meyers, J. P. Lewis, J. Welborn, 1987, Leukemia research.

Features of polycythemia vera in the 8p12 myeloproliferative syndrome.

J. Welborn, Shelly Fenner, R. Parks, 2010, Cancer genetics and cytogenetics.

Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia.

T. Wun, K. Nelson, F. Tablin, 1997, The Journal of laboratory and clinical medicine.

A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study.

M. Grever, F. Appelbaum, S. Balcerzak, 1996, Blood.

Constitutional chromosome aberrations as pathogenetic events in hematologic malignancies.

J. Welborn, 2004, Cancer genetics and cytogenetics.

Germline mutations predisposing to melanoma

J. Welborn, M. Kiuru, A. Toussi, 2020, Journal of cutaneous pathology.

HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.

M. Amylon, M. Cleary, S. Hunger, 1993, Blood.

Blastic mantle cell lymphoma developing concurrently in a patient with chronic myelogenous leukemia and a review of the literature

P. Gumerlock, S. Hatcher, T. Wun, 2004, American journal of hematology.

Acquired Robertsonian translocations are not rare events in acute leukemia and lymphoma.

J. Welborn, 2004, Cancer genetics and cytogenetics.

High-grade neuroendocrine carcinomas display unique cytogenetic aberrations.

J. Welborn, H. Jenks, P. Walling, 2004, Cancer genetics and cytogenetics.

Inversion of chromosome 12 and lineage promiscuity in hematologic malignancies.

J. Welborn, H. Jenks, P. Walling, 2004, Cancer genetics and cytogenetics.

Fibrous hamartoma of infancy: a case report with associated cytogenetic findings.

J. Welborn, T. Konia, R. Lakshminarayanan, 2005, Archives of pathology & laboratory medicine.

Diagnostic and prognostic significance of t(1;3)(p36;q21) in the disorders of hematopoiesis.

J. P. Lewis, J. Welborn, H. Jenks, 1987, Cancer genetics and cytogenetics.

Analysis of mosaic states in amniotic fluid using the in‐situ colony technique

J. Welborn, Jerry P. Lewis, 1990, Clinical genetics.

BLOOD TRANSFUSION REACTIONS : WHICH ARE LIFE-THREATENING AND WHICH ARE NOT?

J. Welborn, J. Hersch, Julie Hersch, 1991 .

Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia.

J. Gregg, Mingyi Chen, J. Welborn, 2016, Human pathology.

Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non‐Hodgkin lymphoma

J. Tuscano, J. Welborn, M. Abedi, 2014, British journal of haematology.

Infusion carboplatin treatment of relapsed and refractory acute leukemia: evidence of efficacy with minimal extramedullary toxicity at intermediate doses.

F. Meyers, J. P. Lewis, J. Welborn, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of reinduction regimens on the clinical course of adult acute nonlymphocytic leukemia.

F. Meyers, J. P. Lewis, J. Welborn, 1988, Leukemia.

Angioleiomyoma: a benign tumor with karyotypic aberrations.

J. Welborn, Shelly Fenner, R. Parks, 2010, Cancer genetics and cytogenetics.

Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?

B. Karlan, H. Rugo, R. Bold, 2020, CA: a cancer journal for clinicians.

Unique clinical features and prognostic significance of the translocation (6;11) in acute leukemia.

A. Hagemeijer, J. Welborn, H. Jenks, 1993, Cancer genetics and cytogenetics.

Trisomy 21 and Cystic Hygromas in Early Gestational Age Fetuses

J. Welborn, N. Timm, Nadine Timm, 1994, American journal of perinatology.

Review: erythropoietin or darbepoetin for anemia in patients with cancer produces both benefits and harms with no increase in survival.

J. Welborn, 2007, ACP journal club.

Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia.

R. Braziel, F. Appelbaum, C. Willman, 1995, Blood.

Impact of polydonor mixed lymphocyte culture media on quantity and quality of myeloid metaphases.

J. P. Lewis, J. Welborn, N. Taylor, 1992, Cancer genetics and cytogenetics.

Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center.

P. Kaesberg, J. Tuscano, J. Welborn, 2022, Leukemia research.